Subscribe to Newsletter

Discovery & Development

Discovery & Development Formulation

Goodbye, Moisture. Hello, mRNA

| Stephanie Vine | 2 min read

Could dry vaccines help improve global access to the latest vaccine technologies?

Discovery & Development Clinical Trials

Positive Opinion for Regeneron’s Libtayo

| Rob Coker | 3 min read

Regeneron Pharmaceuticals’ Israel Lowy explains how a positive CHMP opinion can become good news for cancer patients

Discovery & Development Drug Delivery

Lipid Nanoparticles: From Little League to the Majors

| Bowen Tian | 8 min read

What does the future hold for lipid nanoparticles?

Discovery & Development Drug Discovery

Fresh Hope for ADC Development

| Rob Coker | 6 min read

Historic challenges in ADC Development have not thwarted some players

Discovery & Development Translational Science

From Arctic Fish To New Cell Therapy Preservation Technologies

| Maryam Mahdi | 2 min read

Cryopreservation should maintain the viability of organs and cell therapies, but the process is riddled with challenges.

Discovery & Development Ingredients

Nothing Stands Still: Gibco’s Story from Garage to Industry

| Sponsored by Thermo Fisher Scientific

Old photos, newspaper clippings, and more tell the origin story of a major product line

Discovery & Development Drug Discovery

D is for Decolonize: Sitting Down With Luis Pizarro

| Angus Stewart | 10 min read

The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world

Discovery & Development Drug Discovery

Bacteria to the Future

| Rob Coker | 2 min read

AMR remains a pressing issue, but hydroquinine has yielded some interesting effects on clinically important bacteria

Discovery & Development Drug Discovery

The End of Alopecia?

| Robyn Goforth | 3 min read

Insights into the quest to find an effective treatment for this socially painful condition

Discovery & Development Clinical Trials

Every Disease Has its Day

| Stephanie Vine | 2 min read

Is now finally the time for Alzheimer’s drug development to shine?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register